Eli Lilly's stock surges toward a 5th straight record after an earnings beat and upbeat outlookMarket Watch • 02/06/24
Eli Lilly results blow past estimates on strong Zepbound launch, higher Mounjaro pricesCNBC • 02/06/24
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 GuidancePRNewsWire • 02/06/24
Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A RecordInvestors Business Daily • 02/05/24
Lilly (LLY) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 02/01/24
Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant ValueSeeking Alpha • 01/31/24
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024InvestorPlace • 01/31/24
Norway's giant wealth fund touts possibility of Novo Nordisk, Eli Lilly joining the trillion-dollar clubCNBC • 01/31/24